Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer
Clinical trial NCT02569242 · COMPLETED
Trial details
- NCT number
- NCT02569242
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-14
- Primary completion
- 2020-10-23
- Enrollment
- 419
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.